​

PTC Therapeutics Ownership | Who Owns PTC Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

PTC Therapeutics Ownership Summary

PTC Therapeutics is owned by 40.51% institutional investors, 2.58% insiders, and 56.92% retail investors. Vanguard group is the largest institutional shareholder, holding 11.93% of PTCT shares. Vanguard Health Care Inv is the top mutual fund, with 3.63% of its assets in PTC Therapeutics shares.

PTCT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPTC Therapeutics40.51%2.58%56.92%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group9.18M11.93%$414.33M
Blackrock funding, inc. /de7.90M10.27%$356.55M
Blackrock7.77M10.16%$237.67M
Rtw investments, lp7.39M9.66%$226.08M
Armistice capital6.38M8.29%$287.90M
Wellington management group llp4.79M6.22%$216.09M
Cowen and company3.76M4.91%$114.87M
Toronto dominion bank3.29M4.27%$148.36M
Camber capital management lp3.20M4.16%$144.45M
State street2.75M3.59%$84.07M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Armistice capital6.38M3.93%$287.90M
Rtw investments, lp7.39M3.50%$226.08M
Camber capital management lp3.20M3.34%$144.45M
Cowen and company3.76M3.16%$114.87M
Bioimpact capital434.77K2.79%$19.63M
Palo alto investors lp386.41K2.70%$17.44M
Tang capital management700.00K2.09%$31.60M
Parkman healthcare partners177.37K1.07%$8.01M
Sector gamma as65.25K1.01%$2.95M
Adar1 capital management48.02K0.43%$2.17M

Top Buyers

HolderShares% AssetsChange
Toronto dominion bank3.29M0.23%3.29M
Ubs group1.07M0.01%905.98K
Point72 asset management1.44M0.14%867.50K
Janus henderson group2.33M0.05%455.70K
Pictet asset management sa736.39K0.04%381.32K

Top Sellers

HolderShares% AssetsChange
Wellington management group llp4.79M0.04%-3.11M
State street2.75M0.00%-1.36M
Armistice capital6.38M3.93%-856.90K
Morgan stanley1.52M0.00%-546.28K
Jefferies financial group---522.89K

New Positions

HolderShares% AssetsChangeValue
Toronto dominion bank3.29M0.23%3.29M$148.36M
Woodline partners lp155.88K0.05%155.88K$7.04M
Dimensional fund advisors lp105.05K0.00%105.05K$4.74M
Sector gamma as65.25K1.01%65.25K$2.95M
Raymond james financial48.73K0.00%48.73K$2.20M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-14.00
Byrne asset management-25.00
Federation des caisses desjardins du quebec-30.00
Innealta capital-36.00
Allspring global investments-47.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024111-47.39%31,159,665-60.47%400.39%60-38.14%33-54.79%
Sep 30, 20242113.43%78,815,809-1.28%1020.94%97-21.77%7319.67%
Jun 30, 20242046.81%79,836,937-6.22%1040.84%12445.88%61-11.59%
Mar 31, 20241916.11%85,134,8170.70%1110.87%85-13.27%6923.21%
Dec 31, 2023180-3.23%84,545,7164.22%1120.98%98-4.85%56-5.08%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Health Care Inv2.80M3.63%-2.02M
Vanguard US Total Market Shares ETF2.41M3.06%2.85K
Vanguard Total Stock Mkt Idx Inv2.41M3.06%1.69K
iShares Russell 2000 ETF2.01M2.54%-17.38K
Vanguard Small Cap Index1.97M2.50%1.60K
Vanguard Institutional Extnd Mkt Idx Tr1.18M1.49%1.65K
Vanguard Small Cap Growth Index Inv1.11M1.40%-6.10K
Hartford MidCap Y808.97K1.05%-805.13K
Vanguard Strategic Equity Inv734.67K0.95%-
Fidelity Small Cap Index750.50K0.95%-14.05K

Recent Insider Transactions

DateNameRoleActivityValue
Mar 17, 2025Pauwels Eric CHIEF BUSINESS OFFICERSell$192.62K
Mar 14, 2025Pauwels Eric CHIEF BUSINESS OFFICERSell$246.04K
Mar 17, 2025Pauwels Eric CHIEF BUSINESS OFFICERSell$61.43K
Mar 17, 2025Pauwels Eric CHIEF BUSINESS OFFICERSell$112.52K
Mar 17, 2025Pauwels Eric CHIEF BUSINESS OFFICERSell$17.49K

Insider Transactions Trends

DateBuySell
2025 Q1-45
2024 Q4-23
2024 Q3-1
2024 Q2-6
2024 Q1-22

PTCT Ownership FAQ

Who Owns PTC Therapeutics?

PTC Therapeutics shareholders are primarily institutional investors at 40.51%, followed by 2.58% insiders and 56.91% retail investors. The average institutional ownership in PTC Therapeutics's industry, Biotech Stocks , is 68.48%, which PTC Therapeutics falls below.

Who owns the most shares of PTC Therapeutics?

PTC Therapeutics’s largest shareholders are Vanguard group (9.18M shares, 11.93%), Blackrock funding, inc. /de (7.9M shares, 10.27%), and Blackrock (7.77M shares, 10.16%). Together, they hold 32.36% of PTC Therapeutics’s total shares outstanding.

Does Blackrock own PTC Therapeutics?

Yes, BlackRock owns 10.16% of PTC Therapeutics, totaling 7.77M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 237.67M$. In the last quarter, BlackRock increased its holdings by 207.05K shares, a 2.74% change.

Who is PTC Therapeutics’s biggest shareholder by percentage of total assets invested?

Armistice capital is PTC Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.93% of its assets in 6.38M PTC Therapeutics shares, valued at 287.9M$.

Who is the top mutual fund holder of PTC Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of PTC Therapeutics shares, with 3.63% of its total shares outstanding invested in 2.8M PTC Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools